For more information, contact us at:
(Country Code)+800.3195.3430askcharlesriver@crl.com
*indicates a required field.
The information you provided will be kept confidential.
sept. 02
Charles River continually performs research studies on many aspects of laboratory animal science. One such study has led to the conclusion that Pneumocystis carinii (Pc) is the causative agent for interstitial pneumonia in laboratory rats, previously known by the working name "rat respiratory virus" or "RRV". This work is being submitted for publication.
oct. 06
Charles River recently launched an innovative new website, LabOfTomorrow.com, designed to provide pharmaceutical manufacturers with a personalized journey through the implementation of rapid endotoxin testing solutions. Set in a virtual biopharmaceutical company, the website enables visitors to compare traditional endotoxin testing processes with the PAT-aligned endotoxin testing solutions utilized in the Lab of Tomorrow. These PAT-aligned endotoxin testing solutions have been designed to improve test turnaround time, ensure regulatory compliance, and develop manufacturing efficiencies. The interactive problem-solving journey is complete with animation and narration to provide an engaging and useful experience. To learn more, visit www.laboftomorrow.com.
févr. 17–févr. 18
Charles River Discovery Services will be exhibiting at this event. We offer evaluation of test agents in models of type 1 and type 2 diabetes. We also perform diet-induced obesity studies, where conventional animals (rats or mice) are fed high-fat diets to induce weight gain, diabetes, high blood pressure, dyslipidemia and other obesity phenotypes. Our ability to combine standard physiological assays, histopathology, plasma biomarkers and imaging capabilities set Charles River apart as a premium provider for the assessment of agents intended to treat these metabolic disorders. Visit our booth to discuss how we can help you advance your research.
févr. 08–févr. 10
Charles River will be hosting the 6th European Short Course on Laboratory Animals in Brussels on February 8-10, 2012. The Short Course is designed to educate and update the biomedical research community on current trends and technological advances in the field of laboratory animal science. Some of the topics to be covered during the 2012 European Short Course are the 3Rs and regulatory changes.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
Charles River Laboratories, Inc.